Detailed Program
Thursday, May 09 2024
05:15 PM – 05:30 PM ET - Room 318-323
232: The Novel Autologous AML Vaccine, TriLeukeVax, Stimulates Robust Anti-Leukemic Patient T Cell Responses
Jacob Du
UCSF
Disclosures: J. Du: None.
Related Abstract
This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.